The Pricing Insight Monitor (PIM), from Next Research. The PIM covers a pharma companies own and competitor pricing discount information from a significant sample of European Hospitals and they Buyers for these hospitals.
This syndicated version of the Pricing Insight Monitor (PIM) is therapy focused on 6 markets including Biolgical and Biosimilars products and provide the following information :-
Discounting levels and packages offered by own and competitors (discount % for average, highest and lowest discounts)
The competitive packages offered by each brand/ biosimilar product and how they are received by the key purchasers.
Influencing factors could affect the level of discount offered (e.g. volume purchased, exclusivity of use, support/ training etc).
The PIM will cover the tope 5 European Hospital Markets and extensive robust sample in each market (up to 50 hospitals providing discount information in each country, split by type and size and other variables etc).
The PIM is launching in Early/ Mid 2013, please contact Next Research for further information.
Please contact Russell Mills:
Russellmills@nextresearch.co.uk
+44 (0)7973658388
or Info@nextresearch.co.uk
WWW.NextResearch.Co.UK
nextresearch 
Leave a comment